Corbus Pharmaceuticals Holdings Inc (LTS:0SZI)
$ 15.78 -0.1019 (-0.64%) Market Cap: 195.36 Mil Enterprise Value: 39.61 Mil PE Ratio: 0 PB Ratio: 1.30 GF Score: 21/100

Corbus Pharmaceuticals Holdings Inc to Provide an Overview and Clinical Update for Lenabasum Conference Call Transcript

Jun 21, 2019 / 02:00PM GMT
Release Date Price: $208.82
Ted Jenkins
Corbus Pharmaceuticals Holdings, Inc. - Senior Director of IR & Communications

Good morning, everyone. For those I've not met, my name is Ted Jenkins, I'm Investor Relations at Corbus Pharmaceuticals. We are pleased to have you all join us today for our 2019 Research & Development Day. A warm welcome to all of you as well as to you, all of you joining us through the web.

Before we begin, remarks made during today's presentations may contain forward-looking statements and we encourage you to refer to our filings with the SEC and our corporate website for the latest information on our company. We have an exciting couple of hours for -- planned for you this morning. We'll have a lot of interesting data. Since we're live webcasting, we'll be working straight through, so if you need to take a break, please feel free to get up and do so.

With regard to Q&A, we ask that you hold your questions until the end of each of the presentation sessions. At the end of all of the presentation sessions, we'll be gathering for lunch where you'll be able to meet with members of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot